Karen Prange has served on our board since December 2019. Ms. Prange was most recently Executive Vice President and Chief Executive Officer for the Global Animal Health, Medical and Dental Surgical Group at Henry Schein and a member of its Executive Committee. In this role, she led a business that generated over $6 billion of revenue across three different business units, growing the business to above-market levels in all business segments. Prior to her role at Henry Schein, she was Senior Vice President of Boston Scientific and President of its Urology and Pelvic Health business and served as General Manager of the Micrus Endovascular and Codman Neurovascular business at Johnson & Johnson Company. In addition to general management roles, Ms. Prange has extensive experience in commercial and operational roles, including managing innovation pipelines and acquiring and integrating companies. Ms. Prange currently serves on the boards of Atricure, ViewRay Inc. and WS Audiology. She also serves as Strategic Advisor to Nuvo Group Ltd. and Industrial Advisor to EQT Group. Ms. Prange earned her B.S. in Business Administration with honors from University of Florida and has completed executive education coursework at UCLA Anderson School of Business and Smith College.